Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Polymorphism and OROS-Methylphenidate in ADHD
NCT00842127Phase 4Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Mar 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD), sponsored by Cambridge Health Alliance. Started Mar 2006; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00842127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842127.